Muscle invasive bladder cancer: A single sample patient assay to predict molecular subtypes and benefit of neoadjuvant chemotherapyRoland Seiler, P. Black, Matthew Sommerlad et al.|European Urology Supplements|2017Cited by 1
PD57-04 PROGNOSTIC VALUE OF THE WHO 1973 AND 2004 CLASSIFICATION SYSTEMS FOR GRADE IN NON-MUSCLE-INVASIVE T1 BLADDER CANCERE. Fransen Van De Putte, Bas van Rhijn, Theodorus van der Kwast et al.|The Journal of Urology|2017Cited by 0
Biological characterization of cisplatin-resistant bladder cancer: Implications for second-line treatments?Roland Seiler, P. Black, Ewan A. Gibb et al.|European Urology Supplements|2018Cited by 0
PD48-05 METRIC SUB-STAGE ACCORDING TO MICRO AND EXTENSIVE LAMINA PROPRIA INVASION IMPROVES PROGNOSTICS IN T1 BLADDER CANCERE. Fransen Van De Putte, Bas van Rhijn, Theodorus van der Kwast et al.|The Journal of Urology|2017Cited by 0